{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:59:16Z","timestamp":1761101956134},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.braindev.2011.05.004","type":"journal-article","created":{"date-parts":[[2011,6,23]],"date-time":"2011-06-23T18:58:37Z","timestamp":1308855517000},"page":"98-102","source":"Crossref","is-referenced-by-count":10,"title":["Close monitoring of initial enzyme replacement therapy in a patient with childhood-onset Pompe disease"],"prefix":"10.1016","volume":"34","author":[{"given":"Keiko","family":"Ishigaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terumi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takatoshi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Osawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2011.05.004_b0005","series-title":"Myology","first-page":"1559","article-title":"Acid maltase deficiency","author":"Engel","year":"2003"},{"key":"10.1016\/j.braindev.2011.05.004_b0010","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00415-005-0922-9","article-title":"The natural course of non-classic Pompe\u2019s disease; a review of 225 published cases","volume":"252","author":"Winkel","year":"2005","journal-title":"J. Neurol."},{"key":"10.1016\/j.braindev.2011.05.004_b0015","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/mus.21025","article-title":"Clinical features of late-onset Pompe disease: a prospective cohort study","volume":"38","author":"Wokke","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.braindev.2011.05.004_b0020","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.nurt.2008.08.009","article-title":"Therapeutic approaches in glycogen storage disease type II\/Pompe Disease","volume":"5","author":"Schoser","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.braindev.2011.05.004_b0025","doi-asserted-by":"crossref","first-page":"767","DOI":"10.2147\/TCRM.S5776","article-title":"Alglucosidase alfa: Long term use in the treatment of patients with Pompe disease","volume":"5","author":"Beck","year":"2009","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.braindev.2011.05.004_b0030","first-page":"132","article-title":"Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I\/II clinical trial","volume":"3","author":"Amalfitano","year":"2001","journal-title":"Genet. Med."},{"key":"10.1016\/j.braindev.2011.05.004_b0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2011.05.004_b0040","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/ana.20019","article-title":"Enzyme replacement therapy in late-onset Pompe\u2019s disease: a three-year follow-up","volume":"55","author":"Winkel","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.braindev.2011.05.004_b0045","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.nmd.2008.04.009","article-title":"Eight years experience with enzyme replacement therapy in two children and one adult with Pompe disease","volume":"18","author":"van Capelle","year":"2008","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.braindev.2011.05.004_b0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00415-009-5275-3","article-title":"Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial","volume":"257","author":"Strothotte","year":"2010","journal-title":"J. Neurol."},{"key":"10.1016\/j.braindev.2011.05.004_b0055","unstructured":"doi: http:\/\/www.mext.go.jp\/component\/b_menu\/houdou\/__icsFiles\/afieldfile\/2009\/10\/13\/1285568_1.pdf (Ministry of education, culture, sports, science and technology-Japan, Motor fitness of students in 2009, in Japanese) (accessed, April 1, 2011)."},{"key":"10.1016\/j.braindev.2011.05.004_b0060","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jpeds.2006.12.052","article-title":"Six-minute walk test in children and adolescents","volume":"150","author":"Geiger","year":"2007","journal-title":"J. Pediatr."},{"key":"10.1016\/j.braindev.2011.05.004_b0065","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ejpn.2005.06.004","article-title":"Functional ability and muscle force in healthy children and ambulant Duchenne muscular dystrophy patients","volume":"9","author":"Beenakker","year":"2005","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.braindev.2011.05.004_b0070","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00401-010-0732-8","article-title":"High-density areas on muscle CT in childhood-onset Pompe disease are caused by excess calcium accumulation","volume":"120","author":"Ishigaki","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.braindev.2011.05.004_b0075","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ymgme.2010.06.003","article-title":"Pompe disease: Dramatic improvement in gastrointestinal function following enzyme replacement therapy. A report of three later-onset patients","volume":"101","author":"Bernstein","year":"2010","journal-title":"Mol. Genet. Metab."}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760411001380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760411001380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T21:53:03Z","timestamp":1543701183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760411001380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0387760411001380"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2011.05.004","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}